866-997-4948(US-Canada Toll Free)

Oncimmune (USA) LLC - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 28 Pages


Oncimmune (USA) LLC (Oncimmune) is a medical device company based in the US. The company detects lung cancer in high-risk patients. It offers EarlyCDT, a blood test which aids in the risk assessment and detection. The technology used is autoantibody assay technologies based on biological technology. EarlyCDT detects risk of cancer by detecting bodys immune response, in the form of autointibodies to antigens produced by solid tumor cells. The company carries many tests and researches and it is anticipated, this technology significantly improves the prognosis for those with solid cancers. Oncimmune is headquartered in De Soto, Kansas, the US.

This report is a source for data, analysis and actionable intelligence on the Oncimmune (USA) LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Oncimmune (USA) LLC - Major Products and Services 5
Oncimmune (USA) LLC Pipeline Products by Equipment Type 6
Oncimmune (USA) LLC Pipeline Products by Development Stage 8
Oncimmune (USA) LLC Pipeline Products by Therapy Area 10
EarlyCDT - Breast Cancer 12
EarlyCDT - Breast Cancer Product Status 12
EarlyCDT - Breast Cancer Product Description 12
EarlyCDT - Colon Cancer 13
EarlyCDT - Colon Cancer Product Status 13
EarlyCDT - Colon Cancer Product Description 13
EarlyCDT - Esophagogastric Cancer 14
EarlyCDT - Esophagogastric Cancer Product Status 14
EarlyCDT - Esophagogastric Cancer Product Description 14
EarlyCDT - Liver Cancer 15
EarlyCDT - Liver Cancer Product Status 15
EarlyCDT - Liver Cancer Product Description 15
EarlyCDT - Ovarian Cancer 16
EarlyCDT - Ovarian Cancer Product Status 16
EarlyCDT - Ovarian Cancer Product Description 16
EarlyCDT - Prostate Cancer 17
EarlyCDT - Prostate Cancer Product Status 17
EarlyCDT - Prostate Cancer Product Description 17
EarlyCDT - Prostate Cancer Product Patent Details 17
Oncimmune (USA) LLC - Key Competitors 25
Oncimmune (USA) LLC - Key Employees 26
Oncimmune (USA) LLC - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Table

List of Tables
Oncimmune (USA) LLC, Key Facts 1
Oncimmune (USA) LLC Key Pipeline Products by Equipment Type 1
Oncimmune (USA) LLC Key Pipeline Products by Therapy Area 1
Oncimmune (USA) LLC Key Pipeline Products by Development Stage 1
Oncimmune (USA) LLC, Key Facts 4
Oncimmune (USA) LLC, Major Products and Services 5
Oncimmune (USA) LLC Number of Pipeline Products by Equipment Type 6
Oncimmune (USA) LLC Pipeline Products by Equipment Type 7
Oncimmune (USA) LLC Number of Pipeline Products by Development Stage 8
Oncimmune (USA) LLC Pipeline Products by Development Stage 9
Oncimmune (USA) LLC Number of Pipeline Products by Therapy Area 10
Oncimmune (USA) LLC Pipeline Products by Therapy Area 11
EarlyCDT - Breast Cancer - Product Status 12
EarlyCDT - Breast Cancer - Product Description 12
EarlyCDT - Colon Cancer - Product Status 13
EarlyCDT - Colon Cancer - Product Description 13
EarlyCDT - Esophagogastric Cancer - Product Status 14
EarlyCDT - Esophagogastric Cancer - Product Description 14
EarlyCDT - Liver Cancer - Product Status 15
EarlyCDT - Liver Cancer - Product Description 15
EarlyCDT - Ovarian Cancer - Product Status 16
EarlyCDT - Ovarian Cancer - Product Description 16
EarlyCDT - Prostate Cancer - Product Status 17
EarlyCDT - Prostate Cancer - Product Description 17
EarlyCDT - Prostate Cancer - Patent Details1 17
EarlyCDT - Prostate Cancer - Patent Details2 18
EarlyCDT - Prostate Cancer - Patent Details3 18
EarlyCDT - Prostate Cancer - Patent Details4 19
EarlyCDT - Prostate Cancer - Patent Details5 19
EarlyCDT - Prostate Cancer - Patent Details6 20
EarlyCDT - Prostate Cancer - Patent Details7 20
EarlyCDT - Prostate Cancer - Patent Details8 21
EarlyCDT - Prostate Cancer - Patent Details9 21
EarlyCDT - Prostate Cancer - Patent Details10 22
EarlyCDT - Prostate Cancer - Patent Details11 22
EarlyCDT - Prostate Cancer - Patent Details12 23
EarlyCDT - Prostate Cancer - Patent Details13 23
Oncimmune (USA) LLC, Key Employees 26
Oncimmune (USA) LLC, Subsidiaries 27

List of Chart

List of Figures
Oncimmune (USA) LLC Pipeline Products by Equipment Type 6
Oncimmune (USA) LLC Pipeline Products by Development Stage 8
Oncimmune (USA) LLC Pipeline Products by Therapy Area 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *